Management of primary central nervous system lymphoma Journal Article
| Authors: | El Kamar, F. G.; Abrey, L. E. |
| Article Title: | Management of primary central nervous system lymphoma |
| Abstract: | Primary central nervous system lymphoma (PCNSL) is a unique subtype of non-Hodgkin's lymphoma (NHL). Although PCNSL is both chemosensitive and radiosensitive, it is very difficult to treat and outcomes are substantially inferior when compared with similar extranodal NHL. Furthermore, as a subtype of brain tumors and NHL, the overall incidence has been increasing over the past several decades. This review summarizes the salient clinical features and approach to management of the immunocompetent patient with PCNSL. Copyright © 2004 by the National Comprehensive Cancer Network. All rights reserved. |
| Keywords: | review; multimodality cancer therapy; antineoplastic agents; combined modality therapy; methotrexate; nuclear magnetic resonance imaging; brain tumor; brain neoplasms; magnetic resonance imaging; antineoplastic agent; computer assisted tomography; radiotherapy; tomography, x-ray computed; nonhodgkin lymphoma; brain; lymphoma, non-hodgkin; lymphoma; humans; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 2 |
| Issue: | 4 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2004-07-01 |
| Start Page: | 341 |
| End Page: | 349 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 19795597 |
| DOI/URL: | |
| Notes: | JNCCN J. Nat. Compr. Cancer Netw. -- Cited By (since 1996):3 -- Export Date: 16 June 2014 -- Source: Scopus |
Citation Impact
Related MSK Work